MedWatch

Interim Lundbeck CEO: A strong financial statement

The Danish drug group Lundbeck continues on its course towards the best annual result in the company’s history. This gives rise to pride for CFO and interim CEO Anders Götzsche, who recently presented his first financial statement in position as interim head of the Danish company.

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us free for 14 days

Try a trial subscription for free access to our quality journalism

Frontpage right now

GSK får FDA nik til potentiel revolutionerende HIV-behandling

GSK har fået grønt lys fra de amerikanske lægemyndigheder, FDA, til selskabets mest lovende HIV-middel. Tilladelsen kan være indledningen til et paradigmeskifte inden for HIV-behandling, idet behandlingen reducerer antallet af lægemidler, patienterne behøver at tage.

Latest Top picks in English

Related articles